See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.71▲ 1.25%

Allspring SMID Core (ASCE)

Equity ETF · US-listed · NYSE ARCA · 56 holdings
$32.57 ▼ -0.42 (1.27%)
At close · USD · Volume 1,692,472
52-week range
$24.65 – $36.31
Day's range
$32.44 – $32.72
1-year total return
+26.3%

ASCE price chart

Daily, split-corrected, distributions markedEnd-of-day prices

ASCE fund facts

FundAllspring SMID Core ETF
TickerASCE · NYSE ARCA
Issuer (by our rules)–
Category (by our rules)Equity
Expense ratio0.38%
Holdings56
Net assets (fund, SEC)$118M
Yield (last 12 months)0.18%
DistributionsAnnual
52-week range$24.65 – $36.31
Average volume (3 months)169,401
First price in our data8 Jul 2025
Issuer and category are assigned by StocksXray rules from the fund name. Expense ratio and net assets come from SEC filings; where a fund does not file them (for example grantor trusts) the field stays empty.

Returns and risk

1 month
−3.9%
3 months
−4.5%
6 months
+4.5%
Year to date
+21.4%
1 year
+26.3%
3 years a year
n/a
5 years a year
n/a
10 years a year
n/a
Volatility (1 year)
19.6%
Largest drop, last year
−9.1%
Largest drop in our data
−9.2%
Total return includes distributions, from end-of-day prices adjusted for splits and distributions, to 22 Oct 2026. Periods of 3 years and longer are annualised and shown only when the fund's history is long enough. Volatility is the standard deviation of daily returns over the last year, annualised. Past performance does not guarantee future results.

Cost: expense ratio

0.38% a year

On $10,000 invested that is about $38 a year in fund costs, taken out of the fund's assets.

Source: the fund's prospectus, as filed with the SEC on 23 Jan 2026 (risk/return summary data). Brokerage commissions and the bid-ask spread are separate costs.

Income: distributions

Paid, last 12 months
0.06 USD
Yield on today's price
0.18%
Frequency
Annual
Latest ex-date
22 Dec 2025
Full ASCE dividend history →
Cash paid per current share (restated for share splits), before tax, from EODHD.

ASCE top holdings

#HoldingWeight
1 Carpenter Technology Corp 3.07%
2 Credo Technology Group Holding Ltd 3.05%
3 Onto Innovation Inc 2.72%
4 TTM Technologies Inc 2.68%
5 Blue Bird Corp 2.62%
6 Corcept Therapeutics Inc 2.51%
7 StoneX Group Inc 2.44%
8 Amneal Pharmaceuticals Inc 2.44%
9 Bel Fuse Inc 2.24%
10 Exelixis Inc 2.22%
The top 10 make up 26.0% of the fund, out of 56 holdings.
Positions as of 30 Jun 2026, from the fund's Form N-PORT filed with the SEC. Public N-PORT holdings are quarter-end positions published about 60 days later, so they can be months old and the fund may have changed since.

ASCE: frequently asked questions

What is ASCE?

ASCE is the Allspring SMID Core ETF, listed on NYSE ARCA. By our rules it is classed as "Equity". Its latest SEC filing lists 56 holdings.

What is the expense ratio of ASCE?

ASCE charges 0.38% a year, according to its prospectus filed with the SEC on 23 Jan 2026. On $10,000 that is about $38 a year in fund costs.

Does ASCE pay dividends?

Yes. ASCE paid 0.06 per share over the last 12 months, annual, a trailing yield of 0.18% on today's price. The latest ex-dividend date was 22 Dec 2025.

What does ASCE hold?

The largest holdings in the latest SEC filing are Carpenter Technology Corp (3.1%), Credo Technology Group Holding Ltd (3.0%), Onto Innovation Inc (2.7%). The top 10 together make up 26.0% of the fund.

How has ASCE performed?

Total return including distributions to 22 Oct 2026: 1 year +26.3%. Past performance does not guarantee future results.

Where the numbers come from

Prices and distributions end-of-day data from EODHD; returns are our own calculations from it.
Expense ratio and holdings SEC filings (prospectus risk/return data and Form N-PORT).
Category, issuer and leverage assigned by StocksXray rules from the fund name.
X-Ray look-through our scores applied to the SEC holdings.
Read the methodology →

StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.